<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="373154">
  <stage>Registered</stage>
  <submitdate>19/06/2017</submitdate>
  <approvaldate>27/06/2017</approvaldate>
  <actrnumber>ACTRN12617000927325</actrnumber>
  <trial_identification>
    <studytitle>Improving vitamin D status and related health in young women (part-A)cross-section study</studytitle>
    <scientifictitle>Improving vitamin D status and related health in young women (Part A)-cross-sectional study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>NHMRC Project Grant APP1049065</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Musculoskeletal health </healthcondition>
    <healthcondition>Mood/mental health</healthcondition>
    <healthcondition>Cardiovascular health</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Other public health</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Investigate the association of circulating 25 OHD levels with 
Musculoskeletal health
Mental health
Cardiovascular health</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Association of circulating 25 OHD levels with muscle function
Muscle function measured by using Leonardo jumping mechanography</outcome>
      <timepoint>single assessment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Association of circulating 25 OHD levels with weight</outcome>
      <timepoint>single assessment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>This is a composite secondary outcome: Measure the relationship between 25 OHD levels and UV exposure under Australian conditions, examining both the overall dose and timing of sun exposure
UV exposure was assessed using a wearable UV dosimeter </outcome>
      <timepoint>single assessment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>This is primary outcome: Association of circulating 25 OHD levels with mental health
Assessed by using a validated PHQ-9 questionnaire</outcome>
      <timepoint>Single assessment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>This is primary outcome: Association of circulating 25 OHD levels with  body composition 
Body composition measured by DEXA scan</outcome>
      <timepoint>Single assessment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Association of circulating 25 OHD levels with allergy symptoms
Allergy data collected by questionnaire which was designed for the study</outcome>
      <timepoint>Single assessment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Association of circulating 25 OHD levels with bone density
Bone density measured by DEXA scan</outcome>
      <timepoint>Single measurement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Association of circulating 25 OHD levels with bone turnover markers, obtained from blood test</outcome>
      <timepoint>Single assessment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Female
16-25yrs
Living in Victoria, Australia
Provide informed verbal and written consent
</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>25</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Pregnant or breastfeeding
Plan to move within 2 months of verbal consent
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Random sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>29/04/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>27/11/2015</actualenddate>
    <samplesize>468</samplesize>
    <actualsamplesize>411</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>27/11/2015</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Prof John D Wark	</primarysponsorname>
    <primarysponsoraddress>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, 3052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC </fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Nicola Reavley</sponsorname>
      <sponsoraddress>Level 5, 207 Bouverie Street, The University of Melbourne, VIC 3010</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>A/Prof Marie Pirotta</sponsorname>
      <sponsoraddress>Department of General Practice, The University of Melbourne, 200 Berkeley Street, Carlton VIC 3053	</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Prof George Varigos</sponsorname>
      <sponsoraddress>PO Box 2129, Royal Melbourne Hospital, Parkville VIC 3050</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The part A of the Safe-D study  involves recruitment of participants into a cross-sectional study in order to investigate the association of vitamin D (25-OHD) levels with clinical health indices and related laboratory measures: musculoskeletal health (bone density, bone turnover markers, muscle function); mood/mental health; body composition and weight; and atopic/allergic symptoms. This study recruited 411 young healthy female aged 16 to 25 years old and living in Victoria, Australia through Facebook advertisement. Wide range of data were collected through completing on line survey questionnaires, attending site visit and wearing of a UV dosimeter. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Melbourne Health Human Research Ethics Committee </ethicname>
      <ethicaddress>Royal Melbourne Hospital, Parkville, VIC</ethicaddress>
      <ethicapprovaldate>25/03/2013</ethicapprovaldate>
      <hrec>2013.007</hrec>
      <ethicsubmitdate>2/03/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>John D Wark</name>
      <address>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, 3052</address>
      <phone>+61 3 9342 7109</phone>
      <fax />
      <email>jdwark@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Marjan Tabesh</name>
      <address>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, 3052</address>
      <phone>+61 451664159</phone>
      <fax />
      <email>mtabesh@student.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>John D Wark</name>
      <address>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, 3052</address>
      <phone>+61 3 9342 7109</phone>
      <fax />
      <email>jdwark@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>